Stay updated with breaking news from Bladder tumors. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
the gop senator pushing the immigration compromise says he does frustrated with his fellow republicans intentionally putting out false information. the lead starts right now. that feeling of frustration from senator james langford the conservative oklahoma republican pushing the border deal. mike johnson is just one of many in the gop quick to trash the compromise that at least will try to do something to slow the number of migrants coming into the u.s. we will hear from the house republican and piling on calling the proposed plan capitulation plus senator langford will be here in just minutes. historic rainfall flooding parts of southern california. some cities getting a months worth of rain in one single day. cnn is on the ground and one of the hardest hit areas. the surprising news from buckingham palace this afternoon announcing king charles has cancer. what does the diagnosis mean for the monarchy and how is his prognosis? welcome to the lead i m jake tappe ....
Dr. Thomas Cannell, President and CEO of Sesen Bio, and Dr. Michael Jewett, FRCSC, FACS, to Participate in Canaccord Genuity "Horizons in Oncology" Virtual Conference streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Dr. Thomas Cannell, President and CEO of Sesen Bio, and Dr. Michael Jewett, FRCSC, FACS, to Particip pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
Press release content from PR Newswire. The AP news staff was not involved in its creation. Asieris and Photocure Expand Strategic Partnership to Bladder Cancer Diagnosis and Surgery in Mainland China and Taiwan January 26, 2021 GMT SHANGHAI, Jan. 26, 2021 /PRNewswire/ Asieris Pharmaceuticals announced today that the company has entered into a license agreement with Photocure ASA (Photocure, PHO: OSE) to exclusively register and commercialize Hexvix® in Mainland China and Taiwan. Hexvix® is a drug that preferentially accumulates in bladder cancer cells, making them glow bright pink during Blue Light Cystoscopy (BLC®). It is expected to meet a strong unmet need in the diagnosis and resection of non-muscle invasive bladder cancer (NMIBC) in Mainland China and Taiwan. ....